Navidea Biopharmaceuticals, Inc. NAVB
0.00 0.00
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 65.65K | 531.51K | 915.01K | 657.83K | 1.17M | |
| -119.30K | 531.51K | 913.97K | 651.16K | 1.07M | |
| -14.05M | -12.06M | -10.71M | -10.96M | -10.85M | |
| -15.18M | -11.73M | -10.72M | -10.95M | -16.11M | |
| -0.56 | -0.40 | -0.48 | -0.76 | -1.89 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 2.00M | 4.23M | 2.67M | 1.05M | 3.48M | |
| 4.37M | 6.64M | 7.76M | 4.15M | 7.02M | |
| 12.51M | 6.02M | 5.71M | 5.03M | 4.61M | |
| 2.44M | 749.43K | 1.34M | 1.07M | 316.07K | |
| -8.14M | 624.74K | 1.32M | -1.61M | 1.74M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -8.99M | -10.22M | -8.17M | -9.35M | 4.28M | |
| -390.35K | -329.42K | -412.83K | 770.42K | 953.81K | |
| 7.14M | 12.11M | 10.21M | 6.16M | -4.55M | |
| -63.09K | -25.22K | -134.84K | 27.13K | -46.19K | |
| -2.24M | 1.56M | 1.62M | -2.43M | 680.88K |